Larocent

Larocent uses and dosage

Larocent (Larotrectinib), generic Vitrakvi used to treat only in tumors with certain neurotrophic receptor kinase (NTRK) genes. A kinase is an enzyme that promotes cell growth. There are many types of kinases, which control different phases of cell growth. By blocking a particular enzyme from working, this medication can slow the growth of cancer cells. Larocent manufactured by Incepta Pharma Ltd. in Bangladesh. Larotrectinib has to take orally per day with or without food with a glass of water.

Larocent side effects

The most common adverse reactions of Larotrectinib are: Tiredness, dizziness, cough, constipation, swelling ankles/ feet/ hands, nausea, or vomiting.

Originator brand

Vitrakvi by Array BioPharma & Bayer

Made by

Incepta Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.